BackPrometheus Biosciences Overview

Prometheus Biosciences EBIT

EBIT (Earnings Before Interest and Taxes) analysis for RXDX.

Quarterly EBIT

-$48.94M
↓ 52.47% YoY

As of Mar 31, 2023

Annual EBIT (TTM)

-$162.83M
↓ 50.53% YoY

Trailing 12 months ending Mar 31, 2023

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin